Dr. Sirajeddin Belkhair is Head of Neurosurgery Department and Director of Neurosurgery Residency Program at Hamad Medical Corporation since January 2019. Dr. Sirajeddin joined Hamad medical Corporation in July 2018 as senior consultant at the Department of Neurosurgery. Prior to that, he practiced in United States of America (USA) as an assistant professor in Neurosurgery Department at Saint Louis University Hospital in Missouri and at Michigan state University in Michigan. Dr. Sirajeddin completed his neurosurgery residency training at Dalhousie University in Halifax, Canada. He completed two clinical fellowships from University of Toronto, Canada, first one was in open cerebrovascular neurosurgery and second fellowship was in complex spine surgery. This high-quality training in North America enabled him to perform complex cerebrovascular and spine surgeries and advance neurosurgical treatment provided to patients of Hamad Medical Corporation. Dr. Sirajeddin also obtained a master's degree in clinical epidemiology from University of British Columbia in Vancouver, Canada.
Over the last three years, Dr. Sirajeddin Belkhair had an essential role in advancing research at neurosurgery department at HMC and he is primary author in multiple research projects including randomized control trail that is currently being conducted by him and his team.
